Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Obesity
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Obesity
    TopAbstracts in Obesity 10/14/2008 - (DGNews)
    Prostate Cancer Mortality Is Higher for Overweight Men With High Insulin Secretion Prior to Diagnosis - (DGNews)
    Endocrine Society Releases Guidelines on the Treatment of Paediatric Obesity - (DGNews)
    Weight Loss in Patients Taking Sibutramine Is Greater With Specific Genetic Make-Up - (DGNews)
    TopAbstracts in Obesity 09/30/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Obesity
      Assessment, Prevention and Treatment of Childhood Obesity
      Vascular Protection and CB1 Blockade: Evolving Data
      Obesity and Pulmonary Dysfunction
      Cardiometabolic Risk and Risk Management
      Understanding Metabolic Syndrome: Knowing the Risks

      Webcasts/CME archive

       Recent cases - Obesity
        Reconstruction of the Gastric Passage by a Side-To-Side Gastrogastrostomy After Failed Vertical-Banded Gastroplasty: A Case Report
        Perforated Appendicitis Masquerading as Acute Pancreatitis in a Morbidly Obese Patient.
        Giant Serous Cystadenoma Arising from an Accessory Ovary in a Morbidly Obese 11-Year-Old Girl: A Case Report
        Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication
        Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication

        Cases archive
          




        my personal edition > obesity > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Obese Individuals Experience Modest Weight Loss with Growth-Hormone Therapy: Presented at ENDO

        By Maggie Schwarz

        PHILADELPHIA, PA -- June 24, 2003 -- A controlled dose of growth hormone may help people who are obese to lose weight and maintain the energy to exercise, researchers reported here on June 20th at the Endocrine Society's 85th Annual Meeting.

        Obese individuals exhibit lower growth-hormone levels than people who are not obese. Stewart Albert, MD, professor of internal medicine, division of endocrinology, St. Louis University School of Medicine, in St. Louis, Missouri, led a team of researchers in calculating the amount of growth hormone that would have been present had a person not been obese, and replaced it with nightly injections of growth hormone or placebo for 6 months.

        Thirty-nine volunteers who were nearly 40% overweight (calculated according to an average body mass index of 37) completed the 9-month study. All met with a registered dietician monthly and were encouraged to slowly lose weight by exercising and reducing their daily caloric intake by 500 calories. Twenty-three subjects self-injected growth hormone nightly and 17 self-administered placebo injections.

        Body weight, body fat, and resting metabolic weight were measured in all subjects.

        "People who took growth hormone lost an average of 2.4 kg, or 5.25 pounds. This weight loss was all due to loss of body fat; they did not lose any muscle mass," Dr. Albert said. "Most of the fat loss was in the abdominal area. There were also improvements in high-density lipoprotein cholesterol of about 19%. There was no change in low-density lipoprotein cholesterol, triglycerides, glucose, insulin, insulin sensitivity or blood pressure. One participant had oedema and discontinued therapy."

        "We do not know why people lost weight," said Dr. Albert. "They may have had a decrease in appetite or an increase in energy because they maintained muscle mass and were able to exercise."

        Dr. Albert said, "In the past, when growth hormone was used to restore the body's natural levels, the doses were too high. People had side effects and didn't want to continue. In our study, growth hormone was given at a more balanced dose and people lost weight, which was entirely due to loss of fat."

        Based on this research, Dr. Albert concluded that low-dose growth hormone therapy is useful, and may be incorporated into weight-loss programs.

        This research was supported by a clinical grant from Pharmacia, of New York.


        [Study title: Low-Dose Growth Hormone (GH) as an Adjuvant to Life Style Modifications in the Therapy of Obesity. Abstract OR20-3]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send